
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a big Alzheimer's trial and Valeant Pharmaceuticals' rough week.
GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster is an episode from FierceBiotech Radio. Fierce editors discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a bi...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Mar 18, 2016, 28:41 long, audio available.
Fierce editors discuss the pending retirement of GlaxoSmithKline CEO Andrew Witty, Eli Lilly's bold decision with a big Alzheimer's trial and Valeant Pharmaceuticals' rough week.
You can listen to GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster online on Radio and Podcast. Open the player on this page to stream the available audio.
GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster is an episode from FierceBiotech Radio.
This episode is 28:41 long.
This episode was published on Mar 18, 2016.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster on this page when the episode audio is available from the podcast feed.
GSK's CEO shakeup, Lilly's Alzheimer's uncertainty, and Valeant's latest disaster is from FierceBiotech Radio.
Published Mar 18, 2016 and 28:41 long